Evidence map›Paper›PMID 31836830›Full record

ArticleScientific reports2019

Cosolvent Analysis Toolkit (CAT): a robust hotspot identification platform for cosolvent simulations of proteins to expand the druggable proteome.

Francesc Sabanés Zariquiey, João V de Souza, Agnieszka K Bronowska

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Computational Ligand-Binding Site Prediction.Advances in experimental medicine and biology · 2026
    Review
  5. Article
  6. In situ characterization of amine-forming enzymes shows altered oligomeric state.Protein science : a publication of the Protein Society · 2025
    Article
  7. Article
  8. CosolvKit: a Versatile Tool for Cosolvent MD Preparation and Analysis.Journal of chemical information and modeling · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. In Silico Exploration of the Trypanothione Reductase (TryR) ofInternational journal of molecular sciences · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The druggable genome: Twenty years later.Frontiers in bioinformatics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Francesc Sabanés ZariquieyChemistry - School of Natural and Environmental Sciences, Newcastle University, NE1 7RU, Newcastle, United Kingdom.
João V de SouzaChemistry - School of Natural and Environmental Sciences, Newcastle University, NE1 7RU, Newcastle, United Kingdom.
Agnieszka K BronowskaChemistry - School of Natural and Environmental Sciences, Newcastle University, NE1 7RU, Newcastle, United Kingdom. agnieszka.bronowska@ncl.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cosolvent Molecular Dynamics (MD) simulations are increasingly popular techniques developed for prediction and characterization of allosteric and cryptic binding sites, which can be rendered "druggable" by small molecule ligands. Despite their conceptual simplicity and effectiveness, the analysis of cosolvent MD trajectories relies on pocket volume data, which requires a high level of manual investigation and may introduce a bias. In this work, we present CAT (Cosolvent Analysis Toolkit): an open-source, freely accessible analytical tool, suitable for automated analysis of cosolvent MD trajectories. CAT is compatible with commonly used molecular graphics software packages such as UCSF Chimera and VMD. Using a novel hybrid empirical force field scoring function, CAT accurately ranks the dynamic interactions between the macromolecular target and cosolvent molecules. To benchmark, CAT was used for three validated protein targets with allosteric and orthosteric binding sites, using five chemically distinct cosolvent molecules. For all systems, CAT has accurately identified all known sites. CAT can thus assist in computational studies aiming at identification of protein "hotspots" in a wide range of systems. As an easy-to-use computational tool, we expect that CAT will contribute to an increase in the size of the potentially 'druggable' human proteome.

Indexed as

LigandsMolecular Dynamics SimulationProteomeSoftware2-PropanolAcetamidesAcetanilidesAlgorithmsBenzeneBinding SitesCluster AnalysisHumansImidazolesMacromolecular SubstancesProtein DomainsProteins2-PropanolacetamideAcetamidesacetanilideAcetanilidesBenzeneimidazoleImidazolesLigandsMacromolecular SubstancesProteinsProteomeReceptors, AndrogenSolvents

Identifiers

PMID31836830
PMCPMC6910964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.